Colgate-Palmolive is a multinational consumer goods company that specializes in the production and marketing of a diverse range of household, healthcare, and personal care products
Known primarily for its oral care offerings, including toothpaste and mouthwash, the company also manufactures and sells a variety of other products such as soaps, detergents, and pet nutrition supplies. With a strong emphasis on sustainability, innovation, and health, Colgate-Palmolive strives to enhance the quality of life for consumers around the world while maintaining a commitment to responsible sourcing and environmental stewardship.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how household products stocks fared in Q4, starting with Central Garden & Pet (NASDAQCENT).
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Colgate-Palmolive (NYSECL) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Spectrum Brands (NYSESPB) and the rest of the household products stocks fared in Q4.
Over the past six months, Colgate-Palmolive’s shares (currently trading at $87.88) have posted a disappointing 15.1% loss, well below the S&P 500’s 8.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the household products industry, including Procter & Gamble (NYSEPG) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at household products stocks, starting with Kimberly-Clark (NYSEKMB).
Shares of consumer products company Colgate-Palmolive (NYSECL)
fell 5.2% in the morning session after the company reported underwhelming fourth quarter results. Its EBITDA missed, and its organic revenue fell short of Wall Street's estimates. Also, the full-year sales forecast suggests growth might stay weak in the low single-digit range. Overall, this was a weaker quarter.
Consumer products company Colgate-Palmolive (NYSECL) fell short of the market’s revenue expectations in Q4 CY2024, with sales flat year on year at $4.94 billion. Its non-GAAP profit of $0.91 per share was 2.3% above analysts’ consensus estimates.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Major stock indices have completed their recovery following Monday's sharp drop, buoyed by tech stocks rallying on the back of solid earnings and positive macroeconomic data. The S&P 500 index stands at 6,118 points at midday trading in New York, not far from the all-time high of 6,128 points reached last Friday.
Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic sales rose by 4.3%, and non-GAAP EPS of $0.91 surpassed the consensus. The company expects flat FY25 sales.
